A new study highlights how a decade of investment in research commercialization is translating discoveries into high-impact companies.
Left to right on stage: U of A Chief Research Partnerships Officer Linda Bixby, Senior Vice President for Research and Partnerships Tomás Díaz de la Rubia, Honeywell Aerospace Vice President of Technology Strategy and Innovation Kurt VandenBussche, U of A Professor Pierre Deymier, and Honeywell Aerospace Chief Commercial and Strategy Officer Benjamin Driggs speak on a panel about university-industry partnerships during AZ Tech Week, April 15, 2026.
The University of Arizona ranks among the nation’s leaders in producing founders of billion-dollar startups relative to its size, according to a new Stanford Graduate School of Business analysis.
The university ranked No. 3 in the nation for its likelihood of producing a unicorn company and No. 5 for producing unicorn founders, placing it ahead of institutions including Stanford, MIT and Yale on those measures.
Unlike rankings based on the total number of startup founders, the Stanford analysis measures the likelihood that a university will produce unicorn companies – privately held startups valued at more than $1 billion – and the founders who create them.
The university’s success is not the result of a single startup, inventor or commercialization office. It stems from an innovation ecosystem that the U of A has spent more than a decade intentionally building, piece by piece, university leadership said.
“Being a leader in research and discovery is important and we’re proud of our achievements,” said Tomás Díaz de la Rubia, senior vice president for research and partnerships. “But discoveries alone aren’t enough. The real question is: How do they reach the public? How do they create sustained societal and economic impact? That comes from setting commercialization and the creation and nurturing of startup companies based on university IP as a strategic institutional priority and supporting it with the right team and resources, as Tech Launch Arizona does.”
Tech Launch Arizona, or TLA, the U of A commercialization and startup incubation office and a unit of the Office of Research and Partnerships, helps translate discoveries into solutions that meet society’s pressing needs by protecting and moving newly created intellectual property into commercial licenses and enabling startup formation and business incubation.
Building an innovation ecosystem
According to the Stanford analysis, an outsized number of unicorns have been launched based on U of A intellectual property or by Wildcat alumni. Companies like Ventana Medical Systems, which was started by U of A pathologist Tom Grogan and revolutionized automated cancer diagnostics and tissue staining, have had a huge impact and helped save countless lives. Roche acquired the company in 2008 for $3.4 billion.
“We understand that our faculty and graduate students are at the top of their academic and technical fields,” said Doug Hockstad, chief innovation officer and executive director of TLA. “While their work often results in new inventions, we also understand that research, science and technology are their areas of expertise – not business. We need to work with them to find ways to transition those inventions from the lab to society.”
One ofTLA’s core strategies has been building an ecosystem of entrepreneurs, investors, industry partners and alumni who help transform U of A discoveries into successful products, companies and jobs. In return for mentoring university innovators, these experienced professionals gain early access to emerging technologies and ideas coming out of university research labs. In some cases, they step into leadership roles to help launch new companies.
Funding is another key component. Through the Wildcat Philanthropic Seed Fund, TLA provides early-stage funding for promising startups commercializing U of A technologies. Supported through philanthropy, the evergreen fund strategy is to reinvest proceeds from liquidity events like acquisitions or initial public offerings to support future U of A startups.
In 2026, the fund made its first investments into three startups commercializing U of A inventions: CarbeniumTec out of the Department of Chemistry and Biochemistry, LifeSpan Digital Health from the College of Medicine – Tucson, and UGenome AI, also developed in the College of Medicine – Tucson.
Multiple pathways to impact
Every U of A technology follows its own unique path to market. TLA and its ecosystem partners and supporters discover those pathways and assemble resources to pursue them.
For some, that path is a startup.
SinfoníaRx, a healthcare technology company founded in 2013 to commercialize College of Pharmacy research, was acquired by Tabula Rasa HealthCare in 2017. Based on its high value and strong local impact, the transaction was named Arizona’s Deal of the Year by the Arizona chapter of the Association for Corporate Growth. More importantly, the company’s technology improved service and positive outcomes for patients.
For others, the path is through licensing to an industry partner.
In 2015, Jim Schwiegerling, professor in the James C. Wyant College of Optical Sciences and the Department of Ophthalmology and Vision Science, developed a novel trifocal intraocular lens for cataract patients. The U of A patented the technology and licensed it to vision care company Alcon. Today, the lens design is the core technology behind the company’s PanOptix® brand, with millions of lenses implanted in patients worldwide. The product line has generated immense commercial value for the company while providing a continuing royalty stream to the U of A, Hockstad said.
Innovation also extends well beyond engineering and medicine.
Eller College of Management professor Joseph Valacich and his former doctoral student Jeff Jenkins developed technology that analyzes “digital body language”– including typing speed, hesitations and mouse movements – to detect online fraud. They launched startup NeuroID to commercialize the technology, and Experian acquired the company nine years later.
A decade of measurable growth
Since TLA was established in 2012, the U of A has steadily expanded its commercialization pipeline.
From July 1, 2025, to June 30, 2026, U of A faculty, staff, researchers and graduate students disclosed 372 inventions to be evaluated for commercialization opportunities, the highest annual total in university history. That activity reflects growing interest in commercialization and entrepreneurship across campus while expanding the pipeline of technologies with commercial potential.
Since it began in 2012, TLA has helped launch over 160 startups based on U of A innovations, 71% of which are still active or have been acquired. And since 2015, U of A startups have raised over $1.1 billion.
U of A commercialization efforts are also generating measurable economic impact. An independent economic impact analysis released in April 2026 found that TLA and TLA-linked companies and activities generated $3.3 billion in economic output between 2017 and 2025. In 2025 alone, those businesses and activities generated $457.7 million in economic output, supported 3,070 jobs and produced $16.8 million in tax revenue. The same report projects an additional $2.64 billion in economic output by 2031.
“These innovations and startups are doing much more than strengthening the economy,” Hockstad said. “They’re making people’s lives better. With the University of Arizona at the center and a continuing focus on advanced technology commercialization, we’ll keep launching great companies and products, and we’ll keep attracting more venture capital. Who knows how far we’ll go.”
By Paul Tumarkin, Tech Launch Arizona, and Stephanie Doster, Research and Partnerships